<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38275749</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14010008</ELocationID><Abstract><AbstractText>One of the main concerns related to SARS-CoV-2 infection is the symptoms that could be developed by survivors, known as long COVID, a syndrome characterized by persistent symptoms beyond the acute phase of the infection. This syndrome has emerged as a complex and debilitating condition with a diverse range of manifestations affecting multiple organ systems. It is increasingly recognized for affecting the Central Nervous System, in which one of the most prevalent manifestations is cognitive impairment. The search for effective therapeutic interventions has led to growing interest in Mesenchymal Stem Cell (MSC)-based therapies due to their immunomodulatory, anti-inflammatory, and tissue regenerative properties. This review provides a comprehensive analysis of the current understanding and potential applications of MSC-based interventions in the context of post-acute neurological COVID-19 syndrome, exploring the underlying mechanisms by which MSCs exert their effects on neuroinflammation, neuroprotection, and neural tissue repair. Moreover, we discuss the challenges and considerations specific to employing MSC-based therapies, including optimal delivery methods, and functional treatment enhancements.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Le&#xf3;n-Moreno</LastName><ForeName>Lilia Carolina</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Unidad de Evaluaci&#xf3;n Precl&#xed;nica, Biotecnolog&#xed;a M&#xe9;dica Farmac&#xe9;utica, CONACYT Centro de Investigaci&#xf3;n y Asistencia en Tecnolog&#xed;a y Dise&#xf1;o del Estado de Jalisco (CIATEJ), Guadalajara 44270, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reza-Zald&#xed;var</LastName><ForeName>Edwin Estefan</ForeName><Initials>EE</Initials><AffiliationInfo><Affiliation>Instituto Tecnol&#xf3;gico y de Estudios Superiores de Monterrey, Monterrey 64849, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Sapi&#xe9;ns</LastName><ForeName>Mercedes Azucena</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-0468-0360</Identifier><AffiliationInfo><Affiliation>Unidad de Evaluaci&#xf3;n Precl&#xed;nica, Biotecnolog&#xed;a M&#xe9;dica Farmac&#xe9;utica, CONACYT Centro de Investigaci&#xf3;n y Asistencia en Tecnolog&#xed;a y Dise&#xf1;o del Estado de Jalisco (CIATEJ), Guadalajara 44270, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villafa&#xf1;a-Estarr&#xf3;n</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unidad de Evaluaci&#xf3;n Precl&#xed;nica, Biotecnolog&#xed;a M&#xe9;dica Farmac&#xe9;utica, CONACYT Centro de Investigaci&#xf3;n y Asistencia en Tecnolog&#xed;a y Dise&#xf1;o del Estado de Jalisco (CIATEJ), Guadalajara 44270, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Martin</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratorio de Neurobiolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria, Hospital Cl&#xed;nico San Carlos, IdISSC, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojeda-Hern&#xe1;ndez</LastName><ForeName>Doddy Denise</ForeName><Initials>DD</Initials><Identifier Source="ORCID">0000-0002-7005-8019</Identifier><AffiliationInfo><Affiliation>Laboratorio de Neurobiolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria, Hospital Cl&#xed;nico San Carlos, IdISSC, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matias-Guiu</LastName><ForeName>Jordi A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-5520-2708</Identifier><AffiliationInfo><Affiliation>Laboratorio de Neurobiolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria, Hospital Cl&#xed;nico San Carlos, IdISSC, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez-Pinedo</LastName><ForeName>Ulises</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0003-3097-5557</Identifier><AffiliationInfo><Affiliation>Laboratorio de Neurobiolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria, Hospital Cl&#xed;nico San Carlos, IdISSC, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matias-Guiu</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8162-9043</Identifier><AffiliationInfo><Affiliation>Departamento de Neurolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria, Hospital Cl&#xed;nico San Carlos, IdISSC, Universidad Complutense de Madrid, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canales-Aguirre</LastName><ForeName>Alejandro Arturo</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0003-0918-788X</Identifier><AffiliationInfo><Affiliation>Unidad de Evaluaci&#xf3;n Precl&#xed;nica, Biotecnolog&#xed;a M&#xe9;dica Farmac&#xe9;utica, CONACYT Centro de Investigaci&#xf3;n y Asistencia en Tecnolog&#xed;a y Dise&#xf1;o del Estado de Jalisco (CIATEJ), Guadalajara 44270, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>9790-2021.</GrantID><Agency>Fondo de Desarrollo Cient&#xed;fico de Jalisco</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">exosomes</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mesenchymal stem cells</Keyword><Keyword MajorTopicYN="N">neurological sequelae</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the writing of the manuscript; or in the decision to publish it.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>9</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38275749</ArticleId><ArticleId IdType="pmc">PMC10813738</ArticleId><ArticleId IdType="doi">10.3390/biom14010008</ArticleId><ArticleId IdType="pii">biom14010008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li Y., Bai W., Hashikawa T. The Neuroinvasive Potential of SARS-CoV2 May Play a Role in the Respiratory Failure of COVID-19 Patients. J. Med. Virol. 2020;92:552&#x2013;555. doi: 10.1002/jmv.25728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-L&#xf3;pez G., Cort&#xe9;s-Hern&#xe1;ndez P., Vallejo-Ruiz V., Reyes-Leyva J. SARS-CoV-2: Basic Concepts, Origin and Treatment Advances. Gac. Med. Mex. 2021;157:84&#x2013;89. doi: 10.24875/GMM.M21000524.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/GMM.M21000524</ArticleId><ArticleId IdType="pubmed">34125824</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 14 November 2023)].  Available online:  https://covid19.who.int/</Citation></Reference><Reference><Citation>Loke X.Y., Imran S.A.M., Tye G.J., Wan Kamarul Zaman W.S., Nordin F. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID. Int. J. Mol. Sci. 2021;22:12421. doi: 10.3390/ijms222212421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222212421</ArticleId><ArticleId IdType="pmc">PMC8625432</ArticleId><ArticleId IdType="pubmed">34830303</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyal, Sehgal V., Kapila S., Taneja R., Mehmi P., Gulati N. Review of Neurological Manifestations of SARS-CoV-2. Cureus. 2023;15:e38194. doi: 10.7759/cureus.38194.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.38194</ArticleId><ArticleId IdType="pmc">PMC10223874</ArticleId><ArticleId IdType="pubmed">37257164</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom&#xe1;n-Montes C.M., Flores-Soto Y., Guaracha-Basa&#xf1;ez G.A., Tamez-Torres K.M., Sifuentes-Osornio J., Gonz&#xe1;lez-Lara M.F., de Le&#xf3;n A.P. Post-COVID-19 Syndrome and Quality of Life Impairment in Severe COVID-19 Mexican Patients. Front. Public Health. 2023;11:1155951. doi: 10.3389/fpubh.2023.1155951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1155951</ArticleId><ArticleId IdType="pmc">PMC10225709</ArticleId><ArticleId IdType="pubmed">37255755</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization a Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus.  [(accessed on 14 November 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An Overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Shetty A., Delanerolle G., Zeng Y., Zhang Y., Raymont V., Rathod S., Halabi S., Elliot K., Shi J.Q., et al. A Systematic Review and Meta-Analysis of Long COVID Symptoms. Syst. Rev. 2023;12:88. doi: 10.1186/s13643-023-02250-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzhor E., Leshansky L., Blumenthal J., Barash H., Warshawsky D., Mazor Y., Shtrichman R. Cell-Based Therapy Approaches: The Hope for Incurable Diseases. Regen. Med. 2014;9:649&#x2013;672. doi: 10.2217/rme.14.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/rme.14.35</ArticleId><ArticleId IdType="pubmed">25372080</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F.C., Krause D.S., Deans R.J., Keating A., Prockop D.J., Horwitz E.M. Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement. Cytotherapy. 2006;8:315&#x2013;317. doi: 10.1080/14653240600855905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14653240600855905</ArticleId><ArticleId IdType="pubmed">16923606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jossen V., van den Bos C., Eibl R., Eibl D. Manufacturing Human Mesenchymal Stem Cells at Clinical Scale: Process and Regulatory Challenges. Appl. Microbiol. Biotechnol. 2018;102:3981&#x2013;3994. doi: 10.1007/s00253-018-8912-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-018-8912-x</ArticleId><ArticleId IdType="pmc">PMC5895685</ArticleId><ArticleId IdType="pubmed">29564526</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Blanc K., Davies L.C. MSCs&#x2014;Cells with Many Sides. Cytotherapy. 2018;20:273&#x2013;278. doi: 10.1016/j.jcyt.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2018.01.009</ArticleId><ArticleId IdType="pubmed">29434007</ArticleId></ArticleIdList></Reference><Reference><Citation>Caplan A.I. Mesenchymal Stem Cells: Time to Change the Name! Stem Cells Transl. Med. 2017;6:1445&#x2013;1451. doi: 10.1002/sctm.17-0051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.17-0051</ArticleId><ArticleId IdType="pmc">PMC5689741</ArticleId><ArticleId IdType="pubmed">28452204</ArticleId></ArticleIdList></Reference><Reference><Citation>Caplan A.I. What&#x2019;s in a Name? Tissue Eng. Part A. 2010;16:2415&#x2013;2417. doi: 10.1089/ten.tea.2010.0216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ten.tea.2010.0216</ArticleId><ArticleId IdType="pubmed">20412005</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamshidi E., Babajani A., Soltani P., Niknejad H. Proposed Mechanisms of Targeting COVID-19 by Delivering Mesenchymal Stem Cells and Their Exosomes to Damaged Organs. Stem Cell Rev. Rep. 2021;17:176&#x2013;192. doi: 10.1007/s12015-020-10109-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10109-3</ArticleId><ArticleId IdType="pmc">PMC7799400</ArticleId><ArticleId IdType="pubmed">33432484</ArticleId></ArticleIdList></Reference><Reference><Citation>Akyurekli C., Le Y., Richardson R.B., Fergusson D., Tay J., Allan D.S. A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles. Stem Cell Rev. Rep. 2015;11:150&#x2013;160. doi: 10.1007/s12015-014-9545-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-014-9545-9</ArticleId><ArticleId IdType="pubmed">25091427</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A. Role of Stem Cell Derived Exosomes in Tumor Biology. Int. J. Cancer. 2018;142:1086&#x2013;1092. doi: 10.1002/ijc.31089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.31089</ArticleId><ArticleId IdType="pubmed">28983919</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrzanowski W., Kim S.Y., McClements L. Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated with SARS-CoV-2 Infections. Front. Bioeng. Biotechnol. 2020;8:554. doi: 10.3389/fbioe.2020.00554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2020.00554</ArticleId><ArticleId IdType="pmc">PMC7264098</ArticleId><ArticleId IdType="pubmed">32574317</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Wang S., Zhao R.C. Exosomes from Mesenchymal Stem/Stromal Cells: A New Therapeutic Paradigm. Biomark. Res. 2019;7:8. doi: 10.1186/s40364-019-0159-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40364-019-0159-x</ArticleId><ArticleId IdType="pmc">PMC6450000</ArticleId><ArticleId IdType="pubmed">30992990</ArticleId></ArticleIdList></Reference><Reference><Citation>Askenase P.W. Recommendation: Treatment of Clinical Long COVID Encephalopathies with Nasal Administered Mesenchymal Stromal Cell Extracellular Vesicles. Front. Nanotechnol. 2022;4:987117. doi: 10.3389/fnano.2022.987117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnano.2022.987117</ArticleId></ArticleIdList></Reference><Reference><Citation>Golchin A., Seyedjafari E., Ardeshirylajimi A. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future. Stem Cell Rev. Rep. 2020;16:427&#x2013;433. doi: 10.1007/s12015-020-09973-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-09973-w</ArticleId><ArticleId IdType="pmc">PMC7152513</ArticleId><ArticleId IdType="pubmed">32281052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers C.J., Harman R.J., Bunnell B.A., Schreiber M.A., Xiang C., Wang F.-S., Santidrian A.F., Minev B.R. Rationale for the Clinical Use of Adipose-Derived Mesenchymal Stem Cells for COVID-19 Patients. J. Transl. Med. 2020;18:203. doi: 10.1186/s12967-020-02380-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02380-2</ArticleId><ArticleId IdType="pmc">PMC7232924</ArticleId><ArticleId IdType="pubmed">32423449</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves R.G.d.J., Vasques J.F., da Silva-Junior A.J., Gubert F., Mendez-Otero R. Mesenchymal Stem Cell- and Extracellular Vesicle-Based Therapies for Alzheimer&#x2019;s Disease: Progress, Advantages, and Challenges. Neural Regen. Res. 2023;18:1645&#x2013;1651. doi: 10.4103/1673-5374.361546.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.361546</ArticleId><ArticleId IdType="pmc">PMC10154491</ArticleId><ArticleId IdType="pubmed">36751774</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X.L., Ouyang F.B., Hu L.T., Sun P., Yang J., Sun Y.J., Liao M.S., Lan L.F., Pei Z., Fan Y.H. Mesenchymal Stem Cells Improve Cognitive Impairment and Reduce A&#x3b2; Deposition via Promoting AQP4 Polarity and Relieving Neuroinflammation in Rats with Chronic Hypertension-Induced Cerebral Small-Vessel Disease. Front. Aging Neurosci. 2022;14:883503. doi: 10.3389/fnagi.2022.883503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.883503</ArticleId><ArticleId IdType="pmc">PMC9160459</ArticleId><ArticleId IdType="pubmed">35663575</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghaei Z., Karbalaei N., Namavar M.R., Haghani M., Razmkhah M., Ghaffari M.K., Nemati M. Neuroprotective Effect of Wharton&#x2019;s Jelly-Derived Mesenchymal Stem Cell-Conditioned Medium (WJMSC-CM) on Diabetes-Associated Cognitive Impairment by Improving Oxidative Stress, Neuroinflammation, and Apoptosis. Stem Cells Int. 2023;2023:7852394. doi: 10.1155/2023/7852394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/7852394</ArticleId><ArticleId IdType="pmc">PMC10113062</ArticleId><ArticleId IdType="pubmed">37081849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chopp M., Meng Y., Katakowski M., Xin H., Mahmood A., Xiong Y. Effect of Exosomes Derived from Multipluripotent Mesenchymal Stromal Cells on Functional Recovery and Neurovascular Plasticity in Rats after Traumatic Brain Injury. J. Neurosurg. 2015;122:856&#x2013;867. doi: 10.3171/2014.11.JNS14770.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2014.11.JNS14770</ArticleId><ArticleId IdType="pmc">PMC4382456</ArticleId><ArticleId IdType="pubmed">25594326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappa Villar M.F., L&#xf3;pez Hanotte J., Pardo J., Morel G.R., Mazzolini G., Garc&#xed;a M.G., Reggiani P.C. Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in Rats. Mol. Neurobiol. 2020;57:600&#x2013;615. doi: 10.1007/s12035-019-01729-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01729-z</ArticleId><ArticleId IdType="pubmed">31399955</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Lukiw W.J. SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer&#x2019;s Disease. Front. Cell. Neurosci. 2022;16:937961. doi: 10.3389/fncel.2022.937961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.937961</ArticleId><ArticleId IdType="pmc">PMC9247146</ArticleId><ArticleId IdType="pubmed">35783095</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapoval S.P., Keegan A.D. Perspectives and Potential Approaches for Targeting Neuropilin 1 in SARS-CoV-2 Infection. Mol. Med. 2021;27:162. doi: 10.1186/s10020-021-00423-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00423-y</ArticleId><ArticleId IdType="pmc">PMC8711287</ArticleId><ArticleId IdType="pubmed">34961486</ArticleId></ArticleIdList></Reference><Reference><Citation>Masre S.F., Jufri N.F., Ibrahim F.W., Abdul Raub S.H. Classical and Alternative Receptors for SARS-CoV-2 Therapeutic Strategy. Rev. Med. Virol. 2021;31:1&#x2013;9. doi: 10.1002/rmv.2207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2207</ArticleId><ArticleId IdType="pmc">PMC7883063</ArticleId><ArticleId IdType="pubmed">33368788</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Lazartigues E. Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function. Curr. Hypertens. Rep. 2010;12:170&#x2013;175. doi: 10.1007/s11906-010-0105-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11906-010-0105-7</ArticleId><ArticleId IdType="pmc">PMC3093757</ArticleId><ArticleId IdType="pubmed">20424953</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.-M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory Transmucosal SARS-CoV-2 Invasion as a Port of Central Nervous System Entry in Individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L., Laksono B.M., de Vrij F.M.S., Kushner S.A., Harschnitz O., van Riel D. The Neuroinvasiveness, Neurotropism, and Neurovirulence of SARS-CoV-2. Trends Neurosci. 2022;45:358&#x2013;368. doi: 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Norouzi M., Miar P., Norouzi S., Nikpour P. Nervous System Involvement in COVID-19: A Review of the Current Knowledge. Mol. Neurobiol. 2021;58:3561&#x2013;3574. doi: 10.1007/s12035-021-02347-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02347-4</ArticleId><ArticleId IdType="pubmed">33765290</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zald&#xed;var E.E., Hern&#xe1;ndez-Sapi&#xe9;ns M.A., Minjarez B., G&#xf3;mez-Pinedo U., M&#xe1;rquez-Aguirre A.L., Mateos-D&#xed;az J.C., Matias-Guiu J., Canales-Aguirre A.A. Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System. Front. Immunol. 2020;11:621735. doi: 10.3389/fimmu.2020.621735.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.621735</ArticleId><ArticleId IdType="pmc">PMC7878381</ArticleId><ArticleId IdType="pubmed">33584720</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson M.A., Rhea E.M., Knopp R.C., Banks W.A. Interactions of SARS-CoV-2 with the Blood&#x2013;Brain Barrier. Int. J. Mol. Sci. 2021;22:2681. doi: 10.3390/ijms22052681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052681</ArticleId><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou M.-I., Palaiodimou L., Bakola E., Smyrnis N., Papadopoulou M., Paraskevas G.P., Rizos E., Boutati E., Grigoriadis N., Krogias C., et al. Neurological Manifestations of Long-COVID Syndrome: A Narrative Review. Ther. Adv. Chronic Dis. 2022;13:204062232210768. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The Neurobiology of Long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Whittaker A., Anson M., Harky A. Neurological Manifestations of COVID-19: A Systematic Review and Current Update. Acta Neurol. Scand. 2020;142:14&#x2013;22. doi: 10.1111/ane.13266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13266</ArticleId><ArticleId IdType="pmc">PMC7273036</ArticleId><ArticleId IdType="pubmed">32412088</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya A., Kevadiya B.D., Gendelman H.E., Byrareddy S.N. SARS-CoV-2 Infection Leads to Neurological Dysfunction. J. Neuroimmune Pharmacol. 2020;15:167&#x2013;173. doi: 10.1007/s11481-020-09924-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-020-09924-9</ArticleId><ArticleId IdType="pmc">PMC7244399</ArticleId><ArticleId IdType="pubmed">32447746</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Le Coupanec A., Brison E., Meessen-Pinard M., Talbot P.J. Neuroinvasive and Neurotropic Human Respiratory Coronaviruses: Potential Neurovirulent Agents in Humans. Adv. Exp. Med. Biol. 2014;807:75&#x2013;96. doi: 10.1007/978-81-322-1777-0_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-81-322-1777-0_6</ArticleId><ArticleId IdType="pmc">PMC7121612</ArticleId><ArticleId IdType="pubmed">24619619</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Simani L. Central Nervous System Manifestations of COVID-19: A Systematic Review. J. Neurol. Sci. 2020;413:116832. doi: 10.1016/j.jns.2020.116832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116832</ArticleId><ArticleId IdType="pmc">PMC7151535</ArticleId><ArticleId IdType="pubmed">32299017</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle M.F. Central Nervous System Outcomes of COVID-19. Transl. Res. 2022;241:41&#x2013;51. doi: 10.1016/j.trsl.2021.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.09.002</ArticleId><ArticleId IdType="pmc">PMC8482653</ArticleId><ArticleId IdType="pubmed">34601116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Laurent S., Onur O.A., Kleineberg N.N., Fink G.R., Schweitzer F., Warnke C. A Systematic Review of Neurological Symptoms and Complications of COVID-19. J. Neurol. 2021;268:392&#x2013;402. doi: 10.1007/s00415-020-10067-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10067-3</ArticleId><ArticleId IdType="pmc">PMC7370630</ArticleId><ArticleId IdType="pubmed">32691236</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel S.A.M., Olde Hartman T.C., Lucassen P.L.B.J., van Jaarsveld C.H.M. Post-Acute and Long-COVID-19 Symptoms in Patients with Mild Diseases: A Systematic Review. Fam. Pract. 2022;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-Term Neurologic Outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-Month Neurological and Psychiatric Outcomes in 236 379 Survivors of COVID-19: A Retrospective Cohort Study Using Electronic Health Records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed Subtypes of Post-COVID-19 Syndrome (or Long-COVID) and Their Respective Potential Therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C., Valles-Salgado M., Delgado-&#xc1;lvarez A., Yus M., G&#xf3;mez-Ruiz N., Jorquera M., Polidura C., Gil M.J., Marcos A., Mat&#xed;as-Guiu J., et al. Cognitive Dysfunction Associated with COVID-19: A Comprehensive Neuropsychological Study. J. Psychiatr. Res. 2022;150:40&#x2013;46. doi: 10.1016/j.jpsychires.2022.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.-F., Queneau M., Farid K., Paquet C. Long COVID: Cognitive Complaints (Brain Fog) and Dysfunction of the Cingulate Cortex. J. Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long Covid-Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Liu J., Zhang D., Xu Z., Ji J., Wen C. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front. Immunol. 2020;11:1708. doi: 10.3389/fimmu.2020.01708.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01708</ArticleId><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutal Gursoy G., Yuksel H., Mulkem Simsek I., Oral S., Erdogan Kucukdagli F., Karaman A., Akinci E., Bastug A., Guner H.R., Bektas H. Neurological Presentations in Patients with COVID-19 in Cytokine Storm. Can. J. Neurol. Sci./J. Can. des Sci. Neurol. 2023;50:89&#x2013;95. doi: 10.1017/cjn.2021.247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2021.247</ArticleId><ArticleId IdType="pmc">PMC8649405</ArticleId><ArticleId IdType="pubmed">34866562</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarrott B., Head R., Pringle K.G., Lumbers E.R., Martin J.H. &#x201c;LONG COVID&#x201d;&#x2014;A Hypothesis for Understanding the Biological Basis and Pharmacological Treatment Strategy. Pharmacol. Res. Perspect. 2022;10:e00911. doi: 10.1002/prp2.911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prp2.911</ArticleId><ArticleId IdType="pmc">PMC8929332</ArticleId><ArticleId IdType="pubmed">35029046</ArticleId></ArticleIdList></Reference><Reference><Citation>Thepmankorn P., Bach J., Lasfar A., Zhao X., Souayah S., Chong Z.Z., Souayah N. Cytokine Storm Induced by SARS-CoV-2 Infection: The Spectrum of Its Neurological Manifestations. Cytokine. 2021;138:155404. doi: 10.1016/j.cyto.2020.155404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155404</ArticleId><ArticleId IdType="pmc">PMC7832981</ArticleId><ArticleId IdType="pubmed">33360025</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M., Yus M., G&#xf3;mez-Ruiz N., Polidura C., Gil-Mart&#xed;nez L., Delgado-Alonso C., Jorquera M., G&#xf3;mez-Pinedo U., Matias-Guiu J., Arrazola J., et al. Multimodal Neuroimaging in Post-COVID Syndrome and Correlation with Cognition. Brain. 2023;146:2142&#x2013;2152. doi: 10.1093/brain/awac384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac384</ArticleId><ArticleId IdType="pmc">PMC9620345</ArticleId><ArticleId IdType="pubmed">36288544</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;ez-Cirarda M., Yus-Fuertes M., Sanchez-Sanchez R., Gonzalez-Rosa J.J., Gonzalez-Escamilla G., Gil-Mart&#xed;nez L., Delgado-Alonso C., Gil-Moreno M.J., Valles-Salgado M., Cano-Cano F., et al. Hippocampal Subfield Abnormalities and Biomarkers of Pathologic Brain Changes: From SARS-CoV-2 Acute Infection to Post-COVID Syndrome. EBioMedicine. 2023;94:104711. doi: 10.1016/j.ebiom.2023.104711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104711</ArticleId><ArticleId IdType="pmc">PMC10366393</ArticleId><ArticleId IdType="pubmed">37453364</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., et al. SARS-CoV-2 Is Associated with Changes in Brain Structure in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Cox R.J., Langeland N. Long COVID: A Growing Problem in Need of Intervention. Cell Rep. Med. 2022;3:100552. doi: 10.1016/j.xcrm.2022.100552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100552</ArticleId><ArticleId IdType="pmc">PMC8841141</ArticleId><ArticleId IdType="pubmed">35474749</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C., D&#xed;ez-Cirarda M., Pag&#xe1;n J., P&#xe9;rez-Izquierdo C., Oliver-Mas S., Fern&#xe1;ndez-Romero L., Mart&#xed;nez-Petit &#xc1;., Valles-Salgado M., Gil-Moreno M.J., Yus M., et al. Unraveling Brain Fog in Post-COVID Syndrome: Relationship between Subjective Cognitive Complaints and Cognitive Function, Fatigue, and Neuropsychiatric Symptoms. Eur. J. Neurol. 2023. Online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.16084</ArticleId><ArticleId IdType="pubmed">37797297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayed M., Iohara K. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019. Cell Transplant. 2020;29:096368972095208. doi: 10.1177/0963689720952089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689720952089</ArticleId><ArticleId IdType="pmc">PMC7443577</ArticleId><ArticleId IdType="pubmed">32830527</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S.S., Rojas M. Anti-Inflammatory Effects of Mesenchymal Stem Cells: Novel Concept for Future Therapies. Expert Opin. Biol. Ther. 2008;8:569&#x2013;581. doi: 10.1517/14712598.8.5.569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712598.8.5.569</ArticleId><ArticleId IdType="pubmed">18407762</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison T.J., Jackson M.V., Cunningham E.K., Kissenpfennig A., McAuley D.F., O&#x2019;Kane C.M., Krasnodembskaya A.D. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer. Am. J. Respir. Crit. Care Med. 2017;196:1275&#x2013;1286. doi: 10.1164/rccm.201701-0170OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201701-0170OC</ArticleId><ArticleId IdType="pmc">PMC5694830</ArticleId><ArticleId IdType="pubmed">28598224</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva J.D., Lopes-Pacheco M., Paz A.H.R., Cruz F.F., Melo E.B., de Oliveira M.V., Xisto D.G., Capelozzi V.L., Morales M.M., Pelosi P., et al. Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome*. Crit. Care Med. 2018;46:e132&#x2013;e140. doi: 10.1097/CCM.0000000000002833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002833</ArticleId><ArticleId IdType="pubmed">29116998</ArticleId></ArticleIdList></Reference><Reference><Citation>Khatri M., Richardson L.A., Meulia T. Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Influenza Virus-Induced Acute Lung Injury in a Pig Model. Stem Cell Res. Ther. 2018;9:17. doi: 10.1186/s13287-018-0774-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-0774-8</ArticleId><ArticleId IdType="pmc">PMC5789598</ArticleId><ArticleId IdType="pubmed">29378639</ArticleId></ArticleIdList></Reference><Reference><Citation>Loy H., Kuok D.I.T., Hui K.P.Y., Choi M.H.L., Yuen W., Nicholls J.M., Peiris J.S.M., Chan M.C.W. Therapeutic Implications of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A(H5N1) Virus&#x2014;Associated Acute Lung Injury. J. Infect. Dis. 2019;219:186&#x2013;196. doi: 10.1093/infdis/jiy478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy478</ArticleId><ArticleId IdType="pmc">PMC6306016</ArticleId><ArticleId IdType="pubmed">30085072</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury M., Cuenca J., Cruz F.F., Figueroa F.E., Rocco P.R.M., Weiss D.J. Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19. Eur. Respir. J. 2020;55:2000858. doi: 10.1183/13993003.00858-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00858-2020</ArticleId><ArticleId IdType="pmc">PMC7144273</ArticleId><ArticleId IdType="pubmed">32265310</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang B., Chen J., Li T., Wu H., Yang W., Li Y., Li J., Yu C., Nie F., Ma Z., et al. Clinical Remission of a Critically Ill COVID-19 Patient Treated by Human Umbilical Cord Mesenchymal Stem Cells. Medicine. 2020;99:e21429. doi: 10.1097/MD.0000000000021429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000021429</ArticleId><ArticleId IdType="pmc">PMC7402800</ArticleId><ArticleId IdType="pubmed">32756149</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu L., Niu C., Li R., Huang T., Wang Y., Huang M., Ji N., Zheng Y., Chen X., Shi L., et al. Treatment of Severe COVID-19 with Human Umbilical Cord Mesenchymal Stem Cells. Stem Cell Res. Ther. 2020;11:361. doi: 10.1186/s13287-020-01875-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-020-01875-5</ArticleId><ArticleId IdType="pmc">PMC7432540</ArticleId><ArticleId IdType="pubmed">32811531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zengin R., Beyaz O., Koc E.S., Akinci I.O., Kocagoz S., Sagcan G., Ovali E., Cuhadaroglu C. Mesenchymal Stem Cell Treatment in a Critically Ill COVID-19 Patient: A Case Report. Stem Cell Investig. 2020;7:17. doi: 10.21037/sci-2020-024.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/sci-2020-024</ArticleId><ArticleId IdType="pmc">PMC7561490</ArticleId><ArticleId IdType="pubmed">33110915</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng Z., Zhu R., Hou W., Feng Y., Yang Y., Han Q., Shan G., Meng F., Du D., Wang S., et al. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020;11:216. doi: 10.14336/AD.2020.0228.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0228</ArticleId><ArticleId IdType="pmc">PMC7069465</ArticleId><ArticleId IdType="pubmed">32257537</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Guijo F., Garc&#xed;a-Arranz M., L&#xf3;pez-Parra M., Monedero P., Mata-Mart&#xed;nez C., Santos A., Sagredo V., &#xc1;lvarez-Avello J.-M., Guerrero J.E., P&#xe9;rez-Calvo C., et al. Adipose-Derived Mesenchymal Stromal Cells for the Treatment of Patients with Severe SARS-CoV-2 Pneumonia Requiring Mechanical Ventilation. A Proof of Concept Study. EClinicalMedicine. 2020;25:100454. doi: 10.1016/j.eclinm.2020.100454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100454</ArticleId><ArticleId IdType="pmc">PMC7348610</ArticleId><ArticleId IdType="pubmed">32838232</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu M., Wang H., Bian L., Huang J., Wu D., Zhang R., Fei F., Chen Y., Xia J. Nebulization Therapy with Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Pneumonia. Stem Cell Rev. Rep. 2022;18:2152&#x2013;2163. doi: 10.1007/s12015-022-10398-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-022-10398-w</ArticleId><ArticleId IdType="pmc">PMC9166932</ArticleId><ArticleId IdType="pubmed">35665467</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathi-Kazerooni M., Fattah-Ghazi S., Darzi M., Makarem J., Nasiri R., Salahshour F., Dehghan-Manshadi S.A., Kazemnejad S. Safety and Efficacy Study of Allogeneic Human Menstrual Blood Stromal Cells Secretome to Treat Severe COVID-19 Patients: Clinical Trial Phase I &amp; II. Stem Cell Res. Ther. 2022;13:96. doi: 10.1186/s13287-022-02771-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-022-02771-w</ArticleId><ArticleId IdType="pmc">PMC8899458</ArticleId><ArticleId IdType="pubmed">35255966</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta V., Sengupta S., Lazo A., Woods P., Nolan A., Bremer N. Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19. Stem Cells Dev. 2020;29:747&#x2013;754. doi: 10.1089/scd.2020.0080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2020.0080</ArticleId><ArticleId IdType="pmc">PMC7310206</ArticleId><ArticleId IdType="pubmed">32380908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y.-G., Shi M.-M., Monsel A., Dai C.-X., Dong X., Shen H., Li S.-K., Chang J., Xu C.-L., Li P., et al. Nebulized Exosomes Derived from Allogenic Adipose Tissue Mesenchymal Stromal Cells in Patients with Severe COVID-19: A Pilot Study. Stem Cell Res. Ther. 2022;13:220. doi: 10.1186/s13287-022-02900-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-022-02900-5</ArticleId><ArticleId IdType="pmc">PMC9135389</ArticleId><ArticleId IdType="pubmed">35619189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrabi M., Shahrbaf M.A., Nouri M., Shekari F., Hosseini S.-E., Hashemian S.-M.R., Aliannejad R., Jamaati H., Khavandgar N., Alemi H., et al. Allogenic Mesenchymal Stromal Cells and Their Extracellular Vesicles in COVID-19 Induced ARDS: A Randomized Controlled Trial. Stem Cell Res. Ther. 2023;14:169. doi: 10.1186/s13287-023-03402-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-023-03402-8</ArticleId><ArticleId IdType="pmc">PMC10294333</ArticleId><ArticleId IdType="pubmed">37365605</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin H., Li Y., Cui Y., Yang J.J., Zhang Z.G., Chopp M. Systemic Administration of Exosomes Released from Mesenchymal Stromal Cells Promote Functional Recovery and Neurovascular Plasticity after Stroke in Rats. J. Cereb. Blood Flow Metab. 2013;33:1711&#x2013;1715. doi: 10.1038/jcbfm.2013.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2013.152</ArticleId><ArticleId IdType="pmc">PMC3824189</ArticleId><ArticleId IdType="pubmed">23963371</ArticleId></ArticleIdList></Reference><Reference><Citation>Monsel A., Hauw-Berlemont C., Mebarki M., Heming N., Mayaux J., Nguekap Tchoumba O., Diehl J.-L., Demoule A., Annane D., Marois C., et al. Treatment of COVID-19-Associated ARDS with Mesenchymal Stromal Cells: A Multicenter Randomized Double-Blind Trial. Crit. Care. 2022;26:48. doi: 10.1186/s13054-022-03930-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-03930-4</ArticleId><ArticleId IdType="pmc">PMC8860258</ArticleId><ArticleId IdType="pubmed">35189925</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowdish M.E., Barkauskas C.E., Overbey J.R., Gottlieb R.L., Osman K., Duggal A., Marks M.E., Hupf J., Fernandes E., Leshnower B.G., et al. A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19. Am. J. Respir. Crit. Care Med. 2023;207:261&#x2013;270. doi: 10.1164/rccm.202201-0157OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202201-0157OC</ArticleId><ArticleId IdType="pmc">PMC9896641</ArticleId><ArticleId IdType="pubmed">36099435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaffash Farkhad N., Sedaghat A., Reihani H., Adhami Moghadam A., Bagheri Moghadam A., Khadem Ghaebi N., Khodadoust M.A., Ganjali R., Tafreshian A.R., Tavakol-Afshari J. Mesenchymal Stromal Cell Therapy for COVID-19-Induced ARDS Patients: A Successful Phase 1, Control-Placebo Group, Clinical Trial. Stem Cell Res. Ther. 2022;13:283. doi: 10.1186/s13287-022-02920-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-022-02920-1</ArticleId><ArticleId IdType="pmc">PMC9241239</ArticleId><ArticleId IdType="pubmed">35765103</ArticleId></ArticleIdList></Reference><Reference><Citation>Karyana M., Djaharuddin I., Rif&#x2019;ati L., Arif M., Choi M.K., Angginy N., Yoon A., Han J., Josh F., Arlinda D., et al. Safety of DW-MSC Infusion in Patients with Low Clinical Risk COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial. Stem Cell Res. Ther. 2022;13:134. doi: 10.1186/s13287-022-02812-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-022-02812-4</ArticleId><ArticleId IdType="pmc">PMC8972711</ArticleId><ArticleId IdType="pubmed">35365239</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R., Yan T., Feng Y., Liu Y., Cao H., Peng G., Yang Y., Xu Z., Liu J., Hou W., et al. Mesenchymal Stem Cell Treatment Improves Outcome of COVID-19 Patients via Multiple Immunomodulatory Mechanisms. Cell Res. 2021;31:1244&#x2013;1262. doi: 10.1038/s41422-021-00573-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00573-y</ArticleId><ArticleId IdType="pmc">PMC8546390</ArticleId><ArticleId IdType="pubmed">34702946</ArticleId></ArticleIdList></Reference><Reference><Citation>Grumet M., Sherman J., Dorf B.S. Efficacy of MSC in Patients with Severe COVID-19: Analysis of the Literature and a Case Study. Stem Cells Transl. Med. 2022;11:1103&#x2013;1112. doi: 10.1093/stcltm/szac067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/stcltm/szac067</ArticleId><ArticleId IdType="pmc">PMC9672850</ArticleId><ArticleId IdType="pubmed">36181766</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and Mechanism of Long COVID: A Comprehensive Review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrei Appelt P., Taciana Sisconetto A., Baldo Sucupira K.S.M., Neto E.d.M., Chagas T.d.J., Bazan R., Moura Cabral A., Andrade A.d.O., de Souza L.A.P.S., Jos&#xe9; Luvizutto G. Changes in Electrical Brain Activity and Cognitive Functions Following Mild to Moderate COVID-19: A One-Year Prospective Study After Acute Infection. Clin. EEG Neurosci. 2022;53:543&#x2013;557. doi: 10.1177/15500594221103834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15500594221103834</ArticleId><ArticleId IdType="pmc">PMC9157278</ArticleId><ArticleId IdType="pubmed">35635280</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong C.H., Kim S.M., Lim J.Y., Ryu C.H., Jun J.A., Jeun S.S. Mesenchymal Stem Cells Expressing Brain-Derived Neurotrophic Factor Enhance Endogenous Neurogenesis in an Ischemic Stroke Model. BioMed Res. Int. 2014;2014:129145. doi: 10.1155/2014/129145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/129145</ArticleId><ArticleId IdType="pmc">PMC3933216</ArticleId><ArticleId IdType="pubmed">24672780</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Virgilio L., Ram&#xed;rez-Rodr&#xed;guez G.B., S&#xe1;nchez-Torres C., Ortiz-L&#xf3;pez L., Meraz-R&#xed;os M.A. Soluble Factors from Human Olfactory Neural Stem/Progenitor Cells Influence the Fate Decisions of Hippocampal Neural Precursor Cells. Mol. Neurobiol. 2018;55:8014&#x2013;8037. doi: 10.1007/s12035-018-0906-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0906-2</ArticleId><ArticleId IdType="pubmed">29498005</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zaldivar E., Hern&#xe1;ndez-Sapi&#xe9;ns M., Guti&#xe9;rrez-Mercado Y., Sandoval-&#xc1;vila S., Gomez-Pinedo U., M&#xe1;rquez-Aguirre A., V&#xe1;zquez-M&#xe9;ndez E., Padilla-Camberos E., Canales-Aguirre A. Mesenchymal Stem Cell-Derived Exosomes Promote Neurogenesis and Cognitive Function Recovery in a Mouse Model of Alzheimer&#x2019;s Disease. Neural Regen. Res. 2019;14:1626. doi: 10.4103/1673-5374.255978.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.255978</ArticleId><ArticleId IdType="pmc">PMC6557105</ArticleId><ArticleId IdType="pubmed">31089063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabat M., Bobkov I., Kumar S., Grumet M. Trends in Mesenchymal Stem Cell Clinical Trials 2004&#x2013;2018: Is Efficacy Optimal in a Narrow Dose Range? Stem Cells Transl. Med. 2020;9:17&#x2013;27. doi: 10.1002/sctm.19-0202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.19-0202</ArticleId><ArticleId IdType="pmc">PMC6954709</ArticleId><ArticleId IdType="pubmed">31804767</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsialis S.A., Kourembanas S. Stem Cell&#x2013;Based Therapies for the Newborn Lung and Brain: Possibilities and Challenges. Semin. Perinatol. 2016;40:138&#x2013;151. doi: 10.1053/j.semperi.2015.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semperi.2015.12.002</ArticleId><ArticleId IdType="pmc">PMC4808378</ArticleId><ArticleId IdType="pubmed">26778234</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconi S., Bonaconsa M., Scambi I., Squintani G.M., Rui W., Turano E., Ungaro D., D&#x2019;Agostino S., Barbieri F., Angiari S., et al. Systemic Treatment with Adipose-Derived Mesenchymal Stem Cells Ameliorates Clinical and Pathological Features in the Amyotrophic Lateral Sclerosis Murine Model. Neuroscience. 2013;248:333&#x2013;343. doi: 10.1016/j.neuroscience.2013.05.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2013.05.034</ArticleId><ArticleId IdType="pubmed">23727509</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanilla C.V., Gu H., Liu Q., Zhu T.Z., Zhou C., Johnstone B.H., March K.L., Pascuzzi R.M., Farlow M.R., Du Y. Adipose-Derived Stem Cell Conditioned Media Extends Survival Time of a Mouse Model of Amyotrophic Lateral Sclerosis. Sci. Rep. 2015;5:16953. doi: 10.1038/srep16953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16953</ArticleId><ArticleId IdType="pmc">PMC4653659</ArticleId><ArticleId IdType="pubmed">26586020</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan T.-M., Harn H.-J., Lin H.-P., Chiu S.-C., Lin P.-C., Wang H.-I., Ho L.-I., Chuu C.-P., Chiou T.-W., Hsieh A.-C., et al. The Use of ADSCs as a Treatment for Chronic Stroke. Cell Transplant. 2014;23:541&#x2013;547. doi: 10.3727/096368914X678409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368914X678409</ArticleId><ArticleId IdType="pubmed">24816449</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang G., Liu Y., Zhang Z., Lu Y., Wang Y., Huang J., Li Y., Chen X., Gu X., Wang Y., et al. Mesenchymal Stem Cells Maintain Blood-Brain Barrier Integrity by Inhibiting Aquaporin-4 Upregulation After Cerebral Ischemia. Stem Cells. 2014;32:3150&#x2013;3162. doi: 10.1002/stem.1808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1808</ArticleId><ArticleId IdType="pubmed">25100404</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritfeld G.J., Tewarie R.D.S.N., Vajn K., Rahiem S.T., Hurtado A., Wendell D.F., Roos R.A.C., Oudega M. Bone Marrow Stromal Cell-Mediated Tissue Sparing Enhances Functional Repair after Spinal Cord Contusion in Adult Rats. Cell Transplant. 2012;21:1561&#x2013;1575. doi: 10.3727/096368912X640484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368912X640484</ArticleId><ArticleId IdType="pubmed">22526408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Chang K.-A., Kim J.A., Park H.-G., Ra J.C., Kim H.-S., Suh Y.-H. The Preventive and Therapeutic Effects of Intravenous Human Adipose-Derived Stem Cells in Alzheimer&#x2019;s Disease Mice. PLoS ONE. 2012;7:e45757. doi: 10.1371/journal.pone.0045757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045757</ArticleId><ArticleId IdType="pmc">PMC3458942</ArticleId><ArticleId IdType="pubmed">23049854</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.J., Lee J.K., Lee H., Carter J.E., Chang J.W., Oh W., Yang Y.S., Suh J.-G., Lee B.-H., Jin H.K., et al. Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Improve Neuropathology and Cognitive Impairment in an Alzheimer&#x2019;s Disease Mouse Model through Modulation of Neuroinflammation. Neurobiol. Aging. 2012;33:588&#x2013;602. doi: 10.1016/j.neurobiolaging.2010.03.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.03.024</ArticleId><ArticleId IdType="pubmed">20471717</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J.Y., Park H.J., Kim H.N., Oh S.H., Bae J.-S., Ha H.-J., Lee P.H. Mesenchymal Stem Cells Enhance Autophagy and Increase &#x3b2;-Amyloid Clearance in Alzheimer Disease Models. Autophagy. 2014;10:32&#x2013;44. doi: 10.4161/auto.26508.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.26508</ArticleId><ArticleId IdType="pmc">PMC4389879</ArticleId><ArticleId IdType="pubmed">24149893</ArticleId></ArticleIdList></Reference><Reference><Citation>George S., Hamblin M.R., Abrahamse H. Differentiation of Mesenchymal Stem Cells to Neuroglia: In the Context of Cell Signalling. Stem Cell Rev. Rep. 2019;15:814&#x2013;826. doi: 10.1007/s12015-019-09917-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-019-09917-z</ArticleId><ArticleId IdType="pmc">PMC6925073</ArticleId><ArticleId IdType="pubmed">31515658</ArticleId></ArticleIdList></Reference><Reference><Citation>Scuteri A., Miloso M., Foudah D., Orciani M., Cavaletti G., Tredici G. Mesenchymal Stem Cells Neuronal Differentiation Ability: A Real Perspective for Nervous System Repair? Curr. Stem Cell Res. Ther. 2011;6:82&#x2013;92. doi: 10.2174/157488811795495486.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157488811795495486</ArticleId><ArticleId IdType="pubmed">21190538</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Tang H., Zhu J., Zhang J.H. Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke. Cell Transplant. 2018;27:1825&#x2013;1834. doi: 10.1177/0963689718795424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689718795424</ArticleId><ArticleId IdType="pmc">PMC6300770</ArticleId><ArticleId IdType="pubmed">30251564</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell C.R., Volarevic A., Djonov V., Volarevic V. Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders. Int. J. Mol. Sci. 2021;22:1433. doi: 10.3390/ijms22031433.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031433</ArticleId><ArticleId IdType="pmc">PMC7867043</ArticleId><ArticleId IdType="pubmed">33535376</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman L.S., Romagano M.P., Williams S.F., Rameshwar P. Mesenchymal Stem Cell Therapies in Brain Disease. Semin. Cell Dev. Biol. 2019;95:111&#x2013;119. doi: 10.1016/j.semcdb.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.03.003</ArticleId><ArticleId IdType="pubmed">30922957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Kim Y.E., Hong S., Kim K., Sung D.K., Lee Y., Park W.S., Chang Y.S., Song M. Reactive Microglia and Astrocytes in Neonatal Intraventricular Hemorrhage Model Are Blocked by Mesenchymal Stem Cells. Glia. 2020;68:178&#x2013;192. doi: 10.1002/glia.23712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23712</ArticleId><ArticleId IdType="pubmed">31441125</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P., Gebhart N., Richelson E., Brott T.G., Meschia J.F., Zubair A.C. Mechanism of Mesenchymal Stem Cell&#x2013;Induced Neuron Recovery and Anti-Inflammation. Cytotherapy. 2014;16:1336&#x2013;1344. doi: 10.1016/j.jcyt.2014.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2014.05.007</ArticleId><ArticleId IdType="pubmed">24927715</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh M.Y., Lim S.M., Oh K.-W., Cho K.-A., Park J., Kim K.-S., Lee S.-J., Kwon M.-S., Kim S.H. Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF-&#x3b2; Secretion. Stem Cells Transl. Med. 2016;5:1538&#x2013;1549. doi: 10.5966/sctm.2015-0217.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2015-0217</ArticleId><ArticleId IdType="pmc">PMC5070497</ArticleId><ArticleId IdType="pubmed">27400795</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhang Q., Wang W., Lin F., Wang S., Zhao J. Mesenchymal Stem Cell Therapy for Ischemic Stroke: A Look into Treatment Mechanism and Therapeutic Potential. J. Neurol. 2021;268:4095&#x2013;4107. doi: 10.1007/s00415-020-10138-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10138-5</ArticleId><ArticleId IdType="pubmed">32761505</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham C.J., Redondo-Castro E., Allan S.M. The Therapeutic Potential of the Mesenchymal Stem Cell Secretome in Ischaemic Stroke. J. Cereb. Blood Flow Metab. 2018;38:1276&#x2013;1292. doi: 10.1177/0271678X18776802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X18776802</ArticleId><ArticleId IdType="pmc">PMC6077926</ArticleId><ArticleId IdType="pubmed">29768965</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Ma S., Zhang C., Cao W., Liu M., Li D., Lv P., Xing Q., Qu R., Yao N., et al. Human Umbilical Cord Mesenchymal Stem Cells Transplantation Improves Cognitive Function in Alzheimer&#x2019;s Disease Mice by Decreasing Oxidative Stress and Promoting Hippocampal Neurogenesis. Behav. Brain Res. 2017;320:291&#x2013;301. doi: 10.1016/j.bbr.2016.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2016.12.021</ArticleId><ArticleId IdType="pubmed">28007537</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao X., Wei J., Feng M., Lu S., Li G., Dou W., Ma W., Ma S., An Y., Qin C., et al. Transplantation of Human Bone Marrow-Derived Mesenchymal Stem Cells Promotes Behavioral Recovery and Endogenous Neurogenesis after Cerebral Ischemia in Rats. Brain Res. 2011;1367:103&#x2013;113. doi: 10.1016/j.brainres.2010.10.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.10.063</ArticleId><ArticleId IdType="pubmed">20977892</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.H., Kim H.N., Park H.-J., Shin J.Y., Lee P.H. Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer&#x2019;s Disease Model. Cell Transplant. 2015;24:1097&#x2013;1109. doi: 10.3727/096368914X679237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368914X679237</ArticleId><ArticleId IdType="pubmed">24612635</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins L.F., Costa R.O., Pedro J.R., Aguiar P., Serra S.C., Teixeira F.G., Sousa N., Salgado A.J., Almeida R.D. Mesenchymal Stem Cells Secretome-Induced Axonal Outgrowth Is Mediated by BDNF. Sci. Rep. 2017;7:4153. doi: 10.1038/s41598-017-03592-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-03592-1</ArticleId><ArticleId IdType="pmc">PMC5482809</ArticleId><ArticleId IdType="pubmed">28646200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Lin H., Bai S., Zheng L., Zhang X. Bone Marrow Mesenchymal Stem Cells (BMSCs) Improved Functional Recovery of Spinal Cord Injury Partly by Promoting Axonal Regeneration. Neurochem. Int. 2018;115:80&#x2013;84. doi: 10.1016/j.neuint.2018.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2018.02.007</ArticleId><ArticleId IdType="pubmed">29458076</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahror R.A., Linares G.R., Wang Y., Hsueh S.-C., Wu C.-C., Chuang D.-M., Chiang Y.-H., Chen K.-Y. Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury. J. Neurotrauma. 2020;37:14&#x2013;26. doi: 10.1089/neu.2019.6422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2019.6422</ArticleId><ArticleId IdType="pmc">PMC6921331</ArticleId><ArticleId IdType="pubmed">31298621</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira F., Salgado A. Mesenchymal Stem Cells Secretome: Current Trends and Future Challenges. Neural Regen. Res. 2020;15:75. doi: 10.4103/1673-5374.264455.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.264455</ArticleId><ArticleId IdType="pmc">PMC6862404</ArticleId><ArticleId IdType="pubmed">31535654</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zaldivar E.E., Hern&#xe1;ndez-Sapi&#xe9;ns M.A., Minjarez B., Guti&#xe9;rrez-Mercado Y.K., M&#xe1;rquez-Aguirre A.L., Canales-Aguirre A.A. Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer&#x2019;s Disease. Front. Cell. Neurosci. 2018;12:317. doi: 10.3389/fncel.2018.00317.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00317</ArticleId><ArticleId IdType="pmc">PMC6165870</ArticleId><ArticleId IdType="pubmed">30319358</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukomska B., Stanaszek L., Zuba-Surma E., Legosz P., Sarzynska S., Drela K. Challenges and Controversies in Human Mesenchymal Stem Cell Therapy. Stem Cells Int. 2019;2019:9628536. doi: 10.1155/2019/9628536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9628536</ArticleId><ArticleId IdType="pmc">PMC6481040</ArticleId><ArticleId IdType="pubmed">31093291</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizoso F., Eiro N., Cid S., Schneider J., Perez-Fernandez R. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. Int. J. Mol. Sci. 2017;18:1852. doi: 10.3390/ijms18091852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18091852</ArticleId><ArticleId IdType="pmc">PMC5618501</ArticleId><ArticleId IdType="pubmed">28841158</ArticleId></ArticleIdList></Reference><Reference><Citation>Luarte A., B&#xe1;tiz L.F., Wyneken U., Lafourcade C. Potential Therapies by Stem Cell-Derived Exosomes in CNS Diseases: Focusing on the Neurogenic Niche. Stem Cells Int. 2016;2016:5736059. doi: 10.1155/2016/5736059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5736059</ArticleId><ArticleId IdType="pmc">PMC4853949</ArticleId><ArticleId IdType="pubmed">27195011</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantinieaux D., Quertainmont R., Blacher S., Rossi L., Wanet T., No&#xeb;l A., Brook G., Schoenen J., Franzen R. Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells Improves Recovery after Spinal Cord Injury in Rats: An Original Strategy to Avoid Cell Transplantation. PLoS ONE. 2013;8:e69515. doi: 10.1371/journal.pone.0069515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0069515</ArticleId><ArticleId IdType="pmc">PMC3754952</ArticleId><ArticleId IdType="pubmed">24013448</ArticleId></ArticleIdList></Reference><Reference><Citation>Mead B., Logan A., Berry M., Leadbeater W., Scheven B.A. Paracrine-Mediated Neuroprotection and Neuritogenesis of Axotomised Retinal Ganglion Cells by Human Dental Pulp Stem Cells: Comparison with Human Bone Marrow and Adipose-Derived Mesenchymal Stem Cells. PLoS ONE. 2014;9:e109305. doi: 10.1371/journal.pone.0109305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0109305</ArticleId><ArticleId IdType="pmc">PMC4188599</ArticleId><ArticleId IdType="pubmed">25290916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupcova Skalnikova H. Proteomic Techniques for Characterisation of Mesenchymal Stem Cell Secretome. Biochimie. 2013;95:2196&#x2013;2211. doi: 10.1016/j.biochi.2013.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2013.07.015</ArticleId><ArticleId IdType="pubmed">23880644</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalnikova H., Motlik J., Gadher S.J., Kovarova H. Mapping of the Secretome of Primary Isolates of Mammalian Cells, Stem Cells and Derived Cell Lines. Proteomics. 2011;11:691&#x2013;708. doi: 10.1002/pmic.201000402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201000402</ArticleId><ArticleId IdType="pubmed">21241017</ArticleId></ArticleIdList></Reference><Reference><Citation>Keerthikumar S., Chisanga D., Ariyaratne D., Al Saffar H., Anand S., Zhao K., Samuel M., Pathan M., Jois M., Chilamkurti N., et al. ExoCarta: A Web-Based Compendium of Exosomal Cargo. J. Mol. Biol. 2016;428:688&#x2013;692. doi: 10.1016/j.jmb.2015.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.09.019</ArticleId><ArticleId IdType="pmc">PMC4783248</ArticleId><ArticleId IdType="pubmed">26434508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., Huang M., Zheng M., Dai C., Song Q., Zhang Q., Li Q., Gu X., Chen H., Jiang G., et al. ADSCs-Derived Extracellular Vesicles Alleviate Neuronal Damage, Promote Neurogenesis and Rescue Memory Loss in Mice with Alzheimer&#x2019;s Disease. J. Control. Release. 2020;327:688&#x2013;702. doi: 10.1016/j.jconrel.2020.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2020.09.019</ArticleId><ArticleId IdType="pubmed">32931898</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Ye Y., Su X., He J., Bai W., He X. MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury. Front. Cell. Neurosci. 2017;11:55. doi: 10.3389/fncel.2017.00055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00055</ArticleId><ArticleId IdType="pmc">PMC5329010</ArticleId><ArticleId IdType="pubmed">28293177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M., Shen Y., Wang P., Xie Z., Xu S., Zhu Z.Y., Wang Y., Lyu Y., Wang D., Xu L., et al. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer&#x2019;s Disease. Neurochem. Res. 2018;43:2165&#x2013;2177. doi: 10.1007/s11064-018-2641-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2641-5</ArticleId><ArticleId IdType="pubmed">30259257</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Zhao Y.-C., Niu Z.-F., Fan H.-J., Hou S.-K., Guo X.-Q., Sang L., Lv Q. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles in the Treatment of Human Diseases: Progress and Prospect. World J. Stem Cells. 2021;13:49&#x2013;63. doi: 10.4252/wjsc.v13.i1.49.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v13.i1.49</ArticleId><ArticleId IdType="pmc">PMC7859991</ArticleId><ArticleId IdType="pubmed">33584979</ArticleId></ArticleIdList></Reference><Reference><Citation>Masterson C.H., Curley G.F., Laffey J.G. Modulating the Distribution and Fate of Exogenously Delivered MSCs to Enhance Therapeutic Potential: Knowns and Unknowns. Intensiv. Care Med. Exp. 2019;7:41. doi: 10.1186/s40635-019-0235-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-019-0235-4</ArticleId><ArticleId IdType="pmc">PMC6658643</ArticleId><ArticleId IdType="pubmed">31346794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.Y., Chrzanowski W. Stem Cell-Based Therapy for Lung Disease. Springer International Publishing; Cham, Switzerland: 2019. Stem Cell Delivery Systems and Devices&#x2014;Spraying; pp. 241&#x2013;253.</Citation></Reference><Reference><Citation>Lee N.K., Yang J., Chang E.H., Park S.E., Lee J., Choi S.J., Oh W., Chang J.W., Na D.L. Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer&#x2019;s Disease Mouse Model. PLoS ONE. 2016;11:e0155912. doi: 10.1371/journal.pone.0155912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155912</ArticleId><ArticleId IdType="pmc">PMC4874686</ArticleId><ArticleId IdType="pubmed">27203695</ArticleId></ArticleIdList></Reference><Reference><Citation>Kean T.J., Lin P., Caplan A.I., Dennis J.E. MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int. 2013;2013:732742. doi: 10.1155/2013/732742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/732742</ArticleId><ArticleId IdType="pmc">PMC3755386</ArticleId><ArticleId IdType="pubmed">24000286</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bos J., Ouaamari Y.E., Wouters K., Cools N., Wens I. Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis. Biomolecules. 2022;12:340. doi: 10.3390/biom12020340.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12020340</ArticleId><ArticleId IdType="pmc">PMC8869169</ArticleId><ArticleId IdType="pubmed">35204840</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer U.M., Harting M.T., Jimenez F., Monzon-Posadas W.O., Xue H., Savitz S.I., Laine G.A., Cox C.S. Pulmonary Passage Is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect. Stem Cells Dev. 2009;18:683&#x2013;692. doi: 10.1089/scd.2008.0253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2008.0253</ArticleId><ArticleId IdType="pmc">PMC3190292</ArticleId><ArticleId IdType="pubmed">19099374</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggenhofer E., Benseler V., Kroemer A., Popp F.C., Geissler E.K., Schlitt H.J., Baan C.C., Dahlke M.H., Hoogduijn M.J. Mesenchymal Stem Cells Are Short-Lived and Do Not Migrate beyond the Lungs after Intravenous Infusion. Front. Immunol. 2012;3:297. doi: 10.3389/fimmu.2012.00297.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00297</ArticleId><ArticleId IdType="pmc">PMC3458305</ArticleId><ArticleId IdType="pubmed">23056000</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Xie X., Xiong Y., Liu S., Hu G., Cao W., Wu X. Comparisons of the Therapeutic Effects of Three Different Routes of Bone Marrow Mesenchymal Stem Cell Transplantation in Cerebral Ischemic Rats. Brain Res. 2018;1680:143&#x2013;154. doi: 10.1016/j.brainres.2017.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2017.12.017</ArticleId><ArticleId IdType="pubmed">29274877</ArticleId></ArticleIdList></Reference><Reference><Citation>Evangelista A.F., Vannier-Santos M.A., de Assis Silva G.S., Silva D.N., Juiz P.J.L., Nonaka C.K.V., dos Santos R.R., Soares M.B.P., Villarreal C.F. Bone Marrow-Derived Mesenchymal Stem/Stromal Cells Reverse the Sensorial Diabetic Neuropathy via Modulation of Spinal Neuroinflammatory Cascades. J. Neuroinflammation. 2018;15:189. doi: 10.1186/s12974-018-1224-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1224-3</ArticleId><ArticleId IdType="pmc">PMC6015468</ArticleId><ArticleId IdType="pubmed">29933760</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu G.S., Boukelmoune N., Chiang A.C.A., Peng B., Rao V., Kingsley C., Liu H.-L., Kavelaars A., Kesler S.R., Heijnen C.J. Nasal Administration of Mesenchymal Stem Cells Restores Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice. Oncotarget. 2018;9:35581&#x2013;35597. doi: 10.18632/oncotarget.26272.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.26272</ArticleId><ArticleId IdType="pmc">PMC6238972</ArticleId><ArticleId IdType="pubmed">30473752</ArticleId></ArticleIdList></Reference><Reference><Citation>Argibay B., Trekker J., Himmelreich U., Beiras A., Topete A., Taboada P., P&#xe9;rez-Mato M., Vieites-Prado A., Iglesias-Rey R., Rivas J., et al. Intraarterial Route Increases the Risk of Cerebral Lesions after Mesenchymal Cell Administration in Animal Model of Ischemia. Sci. Rep. 2017;7:40758. doi: 10.1038/srep40758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep40758</ArticleId><ArticleId IdType="pmc">PMC5238501</ArticleId><ArticleId IdType="pubmed">28091591</ArticleId></ArticleIdList></Reference><Reference><Citation>Moll G., Ankrum J.A., Olson S.D., Nolta J.A. Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products. Stem Cells Transl. Med. 2022;11:2&#x2013;13. doi: 10.1093/stcltm/szab005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/stcltm/szab005</ArticleId><ArticleId IdType="pmc">PMC8895495</ArticleId><ArticleId IdType="pubmed">35641163</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppin L., Sokal E., St&#xe9;phenne X. Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives. Cells. 2019;8:1160. doi: 10.3390/cells8101160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101160</ArticleId><ArticleId IdType="pmc">PMC6829440</ArticleId><ArticleId IdType="pubmed">31569696</ArticleId></ArticleIdList></Reference><Reference><Citation>Chance T.C., Rathbone C.R., Kamucheka R.M., Peltier G.C., Cap A.P., Bynum J.A. The Effects of Cell Type and Culture Condition on the Procoagulant Activity of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles. J. Trauma Acute Care Surg. 2019;87:S74&#x2013;S82. doi: 10.1097/TA.0000000000002225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000002225</ArticleId><ArticleId IdType="pubmed">31246910</ArticleId></ArticleIdList></Reference><Reference><Citation>Moll G., Drzeniek N., Kamhieh-Milz J., Geissler S., Volk H.-D., Reinke P. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy. Front. Immunol. 2020;11:1091. doi: 10.3389/fimmu.2020.01091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01091</ArticleId><ArticleId IdType="pmc">PMC7249852</ArticleId><ArticleId IdType="pubmed">32574263</ArticleId></ArticleIdList></Reference><Reference><Citation>Brazzini A., Cantella R., De la Cruz A., Yupanqui J., Le&#xf3;n C., Jorquiera T., Brazzini M., Ortega M., Saenz L.N. Intraarterial Autologous Implantation of Adult Stem Cells for Patients with Parkinson Disease. J. Vasc. Interv. Radiol. 2010;21:443&#x2013;451. doi: 10.1016/j.jvir.2010.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvir.2010.01.008</ArticleId><ArticleId IdType="pubmed">20346882</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabrowska S., Andrzejewska A., Strzemecki D., Muraca M., Janowski M., Lukomska B. Human Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Neuroinflammation Evoked by Focal Brain Injury in Rats. J. Neuroinflammation. 2019;16:216. doi: 10.1186/s12974-019-1602-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1602-5</ArticleId><ArticleId IdType="pmc">PMC6852925</ArticleId><ArticleId IdType="pubmed">31722731</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarygin K.N., Namestnikova D.D., Sukhinich K.K., Gubskiy I.L., Majouga A.G., Kholodenko I.V. Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood&#x2013;Brain Barrier? Cells. 2021;10:2997. doi: 10.3390/cells10112997.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10112997</ArticleId><ArticleId IdType="pmc">PMC8616541</ArticleId><ArticleId IdType="pubmed">34831220</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng L., Peng Q., Wang H., Pan J., Zhou Y., Pan K., Li J., Wu Y., Wang Y. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial. Transl. Stroke Res. 2019;10:170&#x2013;177. doi: 10.1007/s12975-018-0634-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12975-018-0634-y</ArticleId><ArticleId IdType="pubmed">29796934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Na D.L., Lee N.K., Kim A.R., Lee S., Jang H. Intrathecal Injection in a Rat Model: A Potential Route to Deliver Human Wharton&#x2019;s Jelly-Derived Mesenchymal Stem Cells into the Brain. Int. J. Mol. Sci. 2020;21:1272. doi: 10.3390/ijms21041272.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21041272</ArticleId><ArticleId IdType="pmc">PMC7072951</ArticleId><ArticleId IdType="pubmed">32070050</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada A., Sharan J., Band N., Prodromos C. Serious Adverse Events Have Not Been Reported with Spinal Intrathecal Injection of Mesenchymal Stem Cells: A Systematic Review. Curr. Stem Cell Res. Ther. 2023;18:829&#x2013;833. doi: 10.2174/1574888X17666220817125324.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574888X17666220817125324</ArticleId><ArticleId IdType="pubmed">35980065</ArticleId></ArticleIdList></Reference><Reference><Citation>Caplan H., Olson S.D., Kumar A., George M., Prabhakara K.S., Wenzel P., Bedi S., Toledano-Furman N.E., Triolo F., Kamhieh-Milz J., et al. Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application. Front. Immunol. 2019;10:1645. doi: 10.3389/fimmu.2019.01645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01645</ArticleId><ArticleId IdType="pmc">PMC6685059</ArticleId><ArticleId IdType="pubmed">31417542</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamberlain G., Smith H., Rainger G.E., Middleton J. Mesenchymal Stem Cells Exhibit Firm Adhesion, Crawling, Spreading and Transmigration across Aortic Endothelial Cells: Effects of Chemokines and Shear. PLoS ONE. 2011;6:e25663. doi: 10.1371/journal.pone.0025663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025663</ArticleId><ArticleId IdType="pmc">PMC3182247</ArticleId><ArticleId IdType="pubmed">21980522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kan C., Chen L., Hu Y., Lu H., Li Y., Kessler J.A., Kan L. Microenvironmental Factors That Regulate Mesenchymal Stem Cells: Lessons Learned from the Study of Heterotopic Ossification. Histol. Histopathol. 2017;32:977&#x2013;985. doi: 10.14670/HH-11-890.</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/HH-11-890</ArticleId><ArticleId IdType="pmc">PMC5809774</ArticleId><ArticleId IdType="pubmed">28328009</ArticleId></ArticleIdList></Reference><Reference><Citation>Darsalia V., Allison S.J., Cusulin C., Monni E., Kuzdas D., Kallur T., Lindvall O., Kokaia Z. Cell Number and Timing of Transplantation Determine Survival of Human Neural Stem Cell Grafts in Stroke-Damaged Rat Brain. J. Cereb. Blood Flow Metab. 2011;31:235&#x2013;242. doi: 10.1038/jcbfm.2010.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2010.81</ArticleId><ArticleId IdType="pmc">PMC3049487</ArticleId><ArticleId IdType="pubmed">20531461</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti T., Nicholls F., Modo M. Intracerebral Cell Implantation: Preparation and Characterization of Cell Suspensions. Cell Transplant. 2016;25:645&#x2013;664. doi: 10.3727/096368915X690350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3727/096368915X690350</ArticleId><ArticleId IdType="pubmed">26720923</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M.M., Patel B.M. Crossing the Blood&#x2013;Brain Barrier: Recent Advances in Drug Delivery to the Brain. CNS Drugs. 2017;31:109&#x2013;133. doi: 10.1007/s40263-016-0405-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-016-0405-9</ArticleId><ArticleId IdType="pubmed">28101766</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue T., Sugiyama M., Hattori H., Wakita H., Wakabayashi T., Ueda M. Stem Cells from Human Exfoliated Deciduous Tooth-Derived Conditioned Medium Enhance Recovery of Focal Cerebral Ischemia in Rats. Tissue Eng. Part A. 2013;19:24&#x2013;29. doi: 10.1089/ten.tea.2011.0385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ten.tea.2011.0385</ArticleId><ArticleId IdType="pmc">PMC3530935</ArticleId><ArticleId IdType="pubmed">22839964</ArticleId></ArticleIdList></Reference><Reference><Citation>Lochhead J.J., Thorne R.G. Intranasal Delivery of Biologics to the Central Nervous System. Adv. Drug Deliv. Rev. 2012;64:614&#x2013;628. doi: 10.1016/j.addr.2011.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2011.11.002</ArticleId><ArticleId IdType="pubmed">22119441</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeano C., Qiu Z., Mishra A., Farnsworth S.L., Hemmi J.J., Moreira A., Edenhoffer P., Hornsby P.J. The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System. Cell Transplant. 2018;27:501&#x2013;514. doi: 10.1177/0963689718754561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689718754561</ArticleId><ArticleId IdType="pmc">PMC6038044</ArticleId><ArticleId IdType="pubmed">29756518</ArticleId></ArticleIdList></Reference><Reference><Citation>Baak L.M., Wagenaar N., van der Aa N.E., Groenendaal F., Dudink J., Tataranno M.L., Mahamuud U., Verhage C.H., Eijsermans R.M.J.C., Smit L.S., et al. Feasibility and Safety of Intranasally Administered Mesenchymal Stromal Cells after Perinatal Arterial Ischaemic Stroke in the Netherlands (PASSIoN): A First-in-Human, Open-Label Intervention Study. Lancet Neurol. 2022;21:528&#x2013;536. doi: 10.1016/S1474-4422(22)00117-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00117-X</ArticleId><ArticleId IdType="pubmed">35568047</ArticleId></ArticleIdList></Reference><Reference><Citation>Buil B.A., Tackenberg C., Rust R. Editing a Gateway for Cell Therapy across the Blood&#x2014;Brain Barrier. Brain. 2023;146:823&#x2013;841. doi: 10.1093/brain/awac393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac393</ArticleId><ArticleId IdType="pmc">PMC9976985</ArticleId><ArticleId IdType="pubmed">36397727</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Li X., Yang L. Hydrogel Encapsulation: Taking the Therapy of Mesenchymal Stem Cells and Their Derived Secretome to the Next Level. Front. Bioeng. Biotechnol. 2022;10:859927. doi: 10.3389/fbioe.2022.859927.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2022.859927</ArticleId><ArticleId IdType="pmc">PMC9011103</ArticleId><ArticleId IdType="pubmed">35433656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrousis N., Fokina A., Shoichet M.S. Biomaterials for Cell Transplantation. Nat. Rev. Mater. 2018;3:441&#x2013;456. doi: 10.1038/s41578-018-0057-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41578-018-0057-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Golchin A., Shams F., Basiri A., Ranjbarvan P., Kiani S., Sarkhosh-Inanlou R., Ardeshirylajimi A., Gholizadeh-Ghaleh Aziz S., Sadigh S., Rasmi Y. Combination Therapy of Stem Cell-Derived Exosomes and Biomaterials in the Wound Healing. Stem Cell Rev. Rep. 2022;18:1892&#x2013;1911. doi: 10.1007/s12015-021-10309-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-021-10309-5</ArticleId><ArticleId IdType="pubmed">35080745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojeda-Hern&#xe1;ndez D.D., Hern&#xe1;ndez-Sapi&#xe9;ns M.A., Reza-Zald&#xed;var E.E., Canales-Aguirre A., Mat&#xed;as-Guiu J.A., Mat&#xed;as-Guiu J., Mateos-D&#xed;az J.C., G&#xf3;mez-Pinedo U., Sancho-Bielsa F. Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis. Life. 2022;12:1417. doi: 10.3390/life12091417.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12091417</ArticleId><ArticleId IdType="pmc">PMC9504193</ArticleId><ArticleId IdType="pubmed">36143453</ArticleId></ArticleIdList></Reference><Reference><Citation>Maia F.R., Bidarra S.J., Granja P.L., Barrias C.C. Functionalization of Biomaterials with Small Osteoinductive Moieties. Acta Biomater. 2013;9:8773&#x2013;8789. doi: 10.1016/j.actbio.2013.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actbio.2013.08.004</ArticleId><ArticleId IdType="pubmed">23933486</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran J.M., Chen R., Hunt J.A. The Guidance of Human Mesenchymal Stem Cell Differentiation in Vitro by Controlled Modifications to the Cell Substrate. Biomaterials. 2006;27:4783&#x2013;4793. doi: 10.1016/j.biomaterials.2006.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2006.05.001</ArticleId><ArticleId IdType="pubmed">16735063</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran J.M., Chen R., Hunt J.A. Controlling the Phenotype and Function of Mesenchymal Stem Cells in Vitro by Adhesion to Silane-Modified Clean Glass Surfaces. Biomaterials. 2005;26:7057&#x2013;7067. doi: 10.1016/j.biomaterials.2005.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2005.05.008</ArticleId><ArticleId IdType="pubmed">16023712</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinatier C., Guicheux J. Cartilage Tissue Engineering: From Biomaterials and Stem Cells to Osteoarthritis Treatments. Ann. Phys. Rehabil. Med. 2016;59:139&#x2013;144. doi: 10.1016/j.rehab.2016.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rehab.2016.03.002</ArticleId><ArticleId IdType="pubmed">27079583</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasawa K., Tomabechi Y., Ikeda M., Ehara H., Kukimoto-Niino M., Wakiyama M., Podyma-Inoue K.A., Rajapakshe A.R., Watabe T., Shirouzu M., et al. Lysosome-Associated Membrane Proteins-1 and -2 (LAMP-1 and LAMP-2) Assemble via Distinct Modes. Biochem. Biophys. Res. Commun. 2016;479:489&#x2013;495. doi: 10.1016/j.bbrc.2016.09.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.093</ArticleId><ArticleId IdType="pubmed">27663661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K., Zheng X., Jin H., Yu F., Zhao W. Exosomes as CNS Drug Delivery Tools and Their Applications. Pharmaceutics. 2022;14:2252. doi: 10.3390/pharmaceutics14102252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics14102252</ArticleId><ArticleId IdType="pmc">PMC9609403</ArticleId><ArticleId IdType="pubmed">36297688</ArticleId></ArticleIdList></Reference><Reference><Citation>Salunkhe S., Dheeraj, Basak M., Chitkara D., Mittal A. Surface Functionalization of Exosomes for Target-Specific Delivery and in Vivo Imaging &amp; Tracking: Strategies and Significance. J. Control. Release. 2020;326:599&#x2013;614. doi: 10.1016/j.jconrel.2020.07.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2020.07.042</ArticleId><ArticleId IdType="pubmed">32730952</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J.A. Delivery of SiRNA to the Mouse Brain by Systemic Injection of Targeted Exosomes. Nat. Biotechnol. 2011;29:341&#x2013;345. doi: 10.1038/nbt.1807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1807</ArticleId><ArticleId IdType="pubmed">21423189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>